While HO-1 exhibits cytoprotective effects in normal cells by mitigating oxidative stress and inflammation [111,112], its overexpression is observed in several cancer types, including PC, where it contributes to tumor cell survival and resistance to therapy [33,55,113,114]. This evidence concerns the gene HMOX1 and pachyonychia congenita.